# US Transradial Access Devices Market

> US Transradial Access Devices Market Research Report: Size, Share, Trend Analysis By Product (Catheters, Guidewires), By Applications (Drug Administration, Blood Transfusion), By Disease Area (Cardiovascular Disease, Cancer, Strokes), and By End Users (Hospitals, Clinics) - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 7.46%
- **2024:** $ 362.45 Million
- **2025:** $ 389.49 Million
- **2035:** $ 800 Million
- **Key Players:** Terumo Corporation (JP), Boston Scientific Corporation (US), Medtronic plc (IE), Abbott Laboratories (US), Cardinal Health, Inc. (US), B. Braun Melsungen AG (DE), Johnson & Johnson (US), Cook Medical Incorporated (US)

**Report ID:** MRFR/HC/54386-HCR · **Pages:** 200 · **Author:** Rahul Gotadki · **Last Updated:** February 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/us-transradial-access-devices-market-56152

---

## Market Summary

## **US Transradial Access Devices Market Overview**

As per MRFR analysis, the US Transradial Access Devices Market Size was estimated at 395.38 (USD Million) in 2023. The US Transradial Access Devices Market Industry is expected to grow from 450(USD Million) in 2024 to 1,050 (USD Million) by 2035. The US Transradial Access Devices Market CAGR (growth rate) is expected to be around 8.007% during the forecast period (2025 - 2035).

### **Key US Transradial Access Devices Market Trends Highlighted**

A number of important market factors are contributing to the notable expansion of the US Transradial Access Devices Market. One of the main factors is the growing preference for transradial access over conventional femoral access in cardiovascular treatments as medical professionals become aware of its advantages, which include fewer problems and quicker recovery periods. The need for effective and secure vascular access techniques is increasing due to an aging population and an increase in cardiovascular disorders, which is fueling the market's expansion.

Innovations in device design and technology that aim to improve patient outcomes and procedure efficiency are among the opportunities to be investigated in the US transradial access devices market. The creation of cutting-edge materials and technologies that streamline the process may increase market share. Furthermore, transradial procedures-focused training programs for healthcare professionals can boost adoption rates even more, offering healthcare organizations a way to enhance their capabilities.

As additional research confirms the effectiveness and safety of transradial access, there has been a recent movement toward greater education and understanding of its benefits. Professional associations supporting training programs and best practices among healthcare providers are supporting this trend. Additionally, the use of digital health solutions in vascular operations is becoming increasingly popular since it allows for improved pre-and post-operative patient management and real-time monitoring. In the US market, there is a consensus that more creative, secure alternatives that support patient-centered care practices will replace more conventional access methods.

There is potential for more industry advancements as a result of this progression.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

## **US Transradial Access Devices Market Drivers**

### **Increase in Cardiovascular Disease Prevalence**

The increasing prevalence of cardiovascular diseases in the United States is a significant driver for the US Transradial Access Devices Market Industry. According to the American Heart Association, approximately 697,000 Americans died from heart disease in 2020, making it a leading cause of death in the country. With the aging population and rising obesity rates, the demand for less invasive cardiovascular procedures, such as those utilizing transradial access devices, is expected to grow.

The Centers for Disease Control and Prevention (CDC) projects that by 2030, around 43% of adults in the US will be obese, further indicating a potential increase in cardiovascular complications. This scenario enhances the prospects for transradial access devices, which are recognized for their lower complication rates compared to traditional femoral access methods, thus fostering significant market growth.

### **Technological Advancements in Medical Devices**

The ongoing advancements in medical technology, particularly for transradial access devices, are a key market driver. Innovations such as improved catheter designs and enhanced imaging techniques have made transradial procedures safer and more effective. According to the Food and Drug Administration (FDA), there has been a steady increase in the approval of transradial access-related devices, reflecting the rapid pace of Research and Development in the industry.

For instance, advancements have led to reduced radial artery complications and enhanced patient comfort. As manufacturers continue to introduce state-of-the-art products, the US Transradial Access Devices Market Industry is poised for significant expansion, eventually leading to wider adoption of these devices in hospitals and clinics across the US.

### **Increased Awareness and Training for Healthcare Professionals**

Growing awareness and subsequent training initiatives regarding the benefits of transradial access among healthcare professionals have greatly contributed to market growth. Organizations like the Society for Cardiovascular Angiography and Interventions (SCAI) provide numerous educational resources and training programs to healthcare providers, emphasizing the importance of transradial access techniques. As more professionals become skilled in these methodologies, the incidence of transradial procedures is expected to grow, leading to a surge in demand for related devices.

This is essential, as early training adoption has correlated with an increase in the procedural usage rate, enhancing patient outcomes and satisfaction, thereby driving the US Transradial Access Devices Market Industry forward.

## **US Transradial Access Devices Market Segment Insights:**

### **Transradial Access Devices Market Product Insights**

The US Transradial Access Devices Market has gained significant attention due to its robust growth and innovative advancements within the Product segment, primarily focusing on Catheters and Guidewires. This market has evolved as a result of increasing demand for minimally invasive procedures, which are driving the adoption of transradial access methods across various healthcare settings in the United States. Catheters have become indispensable tools in diagnostic and therapeutic procedures, providing enhanced safety and efficiency for patients undergoing cardiac interventions. Their design and functionality contribute to lower complication rates and shorter recovery times, making them a preferred choice among healthcare providers.

Guidewires play a vital role in facilitating access to targeted sites, offering flexibility and precision during complex procedures, particularly in cardiology and radiology. The ongoing advancements in technology have led to the development of sophisticated guidewires that improve maneuverability and reduce vessel trauma, thereby enhancing the overall patient experience. With the American College of Cardiology and other organizations advocating for the adoption of transradial access techniques over traditional femoral methods, the emphasis on training healthcare professionals in the use of Catheters and Guidewires has also increased.

Furthermore, the growing geriatric population and rising prevalence of cardiovascular diseases are contributing to the elevated demand for effective access devices. Regulatory bodies in the US have established guidelines promoting the use of transradial access due to its numerous advantages, fueling market growth. The emphasis on procedural efficiency and patient safety is fostering investments in Research and Development, leading to innovations in Catheters and Guidewires. This scenario encourages manufacturers to focus on enhancing the quality and performance of Transradial Access Devices, which has the potential to expand their market reach significantly in the coming years.

The integration of digital technologies, such as real-time imaging and monitoring systems, is poised to further streamline procedures, improve outcomes, and elevate the overall standard of care within the US healthcare system.

Overall, the Product segment within the US Transradial Access Devices Market reflects a significant shift toward advanced, patient-centric solutions as healthcare providers strive to improve procedural effectiveness and minimize risks associated with access challenges. The continuous evolution and refinement of Catheters and Guidewires underscore their importance in treating an array of conditions while aligning with the broader goals of promoting safe, precise, and cost-effective healthcare practices in the United States.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

### **Transradial Access Devices Market Application Insights**

The US Transradial Access Devices Market exhibits significant growth in the Application segment, featuring areas such as Drug Administration and Blood Transfusion. Drug Administration plays a critical role in enhancing patient comfort and reducing infection risks, as transradial access is increasingly favored for its minimal complications compared to traditional approaches. Meanwhile, Blood Transfusion is a vital application, as it ensures the effective delivery of blood products to patients in need, and transradial techniques streamline this process, increasing efficiency in emergency and clinical settings.

Both applications are witnessing advancements driven by increased procedural safety and growing adoption rates among healthcare providers. Furthermore, the US healthcare landscape emphasizes boosting patient outcomes alongside cost efficiency, which positions these applications as essential components. As hospitals and clinics continue to prioritize transradial approaches, the focus on innovation within these applications will likely present considerable opportunities within the US Transradial Access Devices Market. The steady growth and development of such applications are indicative of their critical role in ensuring effective patient care and satisfaction.

### **Transradial Access Devices Market Disease Area Insights**

The US Transradial Access Devices Market encompasses various disease areas, notably Cardiovascular Disease, Cancer, and Strokes, each showing significant relevance to healthcare delivery in the region. Cardiovascular Disease remains a leading cause of mortality in the United States, driving the demand for innovative transradial access solutions that offer improved procedural outcomes and reduced complications. Cancer treatment often involves complex interventions where transradial access can enhance safety and recovery times, positioning it as a critical advancement in oncological practices.

Similarly, the management and treatment of Strokes highlight the need for rapid and effective access techniques, making transradial devices a crucial component in emergent care settings. Together, these disease areas contribute to the ongoing evolution of the US Transradial Access Devices Market, influenced by factors such as aging demographics and advancements in medical technologies. The segmentation reflects the growing focus on minimally invasive techniques, aiming to improve patient comfort and procedural efficacy across various medical disciplines.

With the increasing prevalence of these diseases, the demand for transradial access devices is poised to escalate, marking significant opportunities for growth and innovation within the industry.

### **Transradial Access Devices Market End User Insights**

The End User segment of the US Transradial Access Devices Market is primarily comprised of Hospitals and Clinics, where the demand for these devices is significantly driven by the increasing preference for minimally invasive procedures. Hospitals play a crucial role in the utilization of Transradial Access Devices, as they often implement advanced technologies to enhance patient outcomes and reduce recovery times. The rise in cardiovascular diseases has further accentuated the need for efficient access devices within these facilities.

Clinics, on the other hand, contribute to market growth by providing accessible outpatient treatments and procedures that leverage transradial approaches, enhancing patient convenience and safety.

This segment's importance is underscored by the consistent focus on improving healthcare delivery in the US, supported by investments in technology and a shift towards outpatient care models. Consequently, both Hospitals and Clinics are significant players in shaping the landscape of the US Transradial Access Devices Market, fostering a trend towards increased adoption and integration of advanced devices in routine practice. The emphasis on patient-centered care and improved procedural efficiency continues to drive the relevance of this segment in the broader market context.

## **US Transradial Access Devices Market Key Players and Competitive Insights:**

The US Transradial Access Devices Market has experienced significant growth and innovation over recent years, driven by increasing demand for minimally invasive cardiac procedures. As healthcare providers continue to evolve their practices, the emphasis on safety, efficiency, and improved patient outcomes has placed transradial access at the forefront of interventional cardiology. This shift in preference from traditional femoral access to radial access has fostered a competitive landscape where companies strive to innovate in device technology, improve procedural techniques, and expand their market reach.

The market is characterized by a variety of players ranging from established medical device manufacturers to emerging startups, with each aiming to enhance their product offerings and address the specific needs of healthcare providers and patients in the US.

Endologix has positioned itself as a key player within the US Transradial Access Devices Market, leveraging its innovative technologies and commitment to improving patient outcomes. The company has developed a range of transradial access devices that are designed to facilitate a seamless and efficient interventional experience. Endologix benefits from a strong reputation built on quality and reliability, enabling it to establish trust with healthcare professionals across the country.

Furthermore, the company’s effective marketing strategies and robust distribution networks have reinforced its market presence, allowing for the widespread adoption of its devices in a variety of healthcare settings, including hospitals and outpatient clinics. The focus on continuous improvement and responsiveness to market needs has marked Endologix as an essential contributor to advancing transradial access techniques in the US.

Svelte Medical Systems stands out in the US Transradial Access Devices Market through its distinctive approach to device design and innovation. With a strong focus on developing advanced products that promote easier and safer transradial access, Svelte Medical Systems has cultivated a niche within the market, particularly with its proprietary technology aimed at enhancing procedural outcomes. The company offers key products such as specialized delivery systems and catheters, which have gained recognition among healthcare providers for their effectiveness. Svelte Medical Systems’ strengths lie in its commitment to research and development, driving innovation that addresses current limitations in transradial access.

Additionally, the company has been engaged in strategic partnerships and collaborations that have bolstered its market presence, further solidifying its reputation. By focusing on creating products that streamline interventional processes and enhance patient safety, Svelte Medical Systems continues to play a vital role in the evolution of transradial access in the US healthcare landscape.

### **Key Companies in the US Transradial Access Devices Market Include:**

- Endologix
- Svelte Medical Systems
- [Medtronic](https://www.medtronic.com/en-us/healthcare-professionals/products.html)
- Abbott Laboratories
- Penumbra
- Asahi Intecc
- Johnson & Johnson
- Terumo
- Cardinal Health
- Merit Medical Systems
- Boston Scientific
- Spectrum Dynamics Medical
- Cook Medical
- Braun Melsungen AG

### **US Transradial Access Devices Market Industry Developments**

The US Transradial Access Devices Market has seen significant developments recently, particularly with advancements in technology and product offerings. Companies such as Medtronic and Abbott Laboratories are continually enhancing their transradial access devices with innovations aimed at improving patient outcomes and procedural efficiency. In terms of market growth, the demand for minimally invasive procedures has propelled the valuation of this market segment, with projections indicating a substantial increase in surgical applications. Current affairs also spotlight the collaborative efforts among key players, including Endologix and Terumo, to expand their market reach and product capabilities.

Notably, there have been recent mergers and acquisitions; for instance, in September 2023, Johnson and Johnson announced the acquisition of a digital health platform to enhance its cardiovascular portfolio. Additionally, Boston Scientific has committed to significant investments in Research and Development aimed at new transradial devices. Overall, the focus on safety, efficacy, and patient-centered care continues to drive the trends in the US Transradial Access Devices Market, reflecting the increasing importance of these devices in clinical practice over the past few years.

## **Transradial Access Devices Market Segmentation Insights**

### **Transradial Access Devices Market Product Outlook**

- Catheters
- [Guidewires](../../reports/guidewires-market-11544)

### **Transradial Access Devices Market Application Outlook**

- Drug Administration
- Blood Transfusion

### **Transradial Access Devices Market Disease Area Outlook**

- Cardiovascular Disease
- Cancer
- Strokes

### **Transradial Access Devices Market End User Outlook**

- Hospitals
- Clinics

## Market Drivers

### Expansion of Healthcare Infrastructure

The expansion of healthcare infrastructure in the United States is a key driver for the transradial access-devices market. As hospitals and clinics invest in modern facilities and advanced medical technologies, the availability of transradial access devices is likely to increase. This expansion is supported by government initiatives aimed at improving healthcare access and quality. With more healthcare facilities equipped to perform transradial procedures, the market is expected to witness substantial growth, reflecting the ongoing commitment to enhancing healthcare delivery across the nation.

### Technological Innovations in Medical Devices

Technological advancements play a crucial role in shaping the transradial access-devices market. Innovations such as advanced imaging techniques, improved catheter designs, and enhanced safety features are driving the adoption of these devices. For instance, the introduction of next-generation catheters with better maneuverability and flexibility has led to increased procedural success rates. The market for these innovative devices is expected to reach $1.5 billion by 2026, indicating a robust growth trajectory. As healthcare providers seek to improve patient outcomes, the demand for technologically advanced transradial access devices is likely to rise.

### Growing Prevalence of Cardiovascular Diseases

The transradial access-devices market is significantly influenced by the rising prevalence of cardiovascular diseases in the United States. With heart disease remaining a leading cause of mortality, the demand for effective diagnostic and interventional procedures is increasing. Data suggests that approximately 697,000 deaths occur annually due to heart disease, prompting healthcare systems to adopt more efficient treatment methods. This trend is likely to drive the growth of the transradial access-devices market, as these devices are essential for performing various cardiovascular interventions, thereby addressing the urgent need for effective healthcare solutions.

### Increased Focus on Patient Safety and Comfort

Patient safety and comfort are becoming paramount in healthcare, influencing the transradial access-devices market. The shift towards procedures that minimize patient discomfort and reduce the risk of complications is driving the adoption of transradial access techniques. Studies indicate that transradial access is associated with lower rates of bleeding and vascular complications compared to traditional femoral access. As healthcare providers prioritize patient-centered care, the demand for devices that enhance safety and comfort is expected to grow, further propelling the transradial access-devices market.

### Rising Demand for Minimally Invasive Procedures

The transradial access-devices market is experiencing a notable increase in demand due to the growing preference for minimally invasive procedures among healthcare providers and patients. This trend is driven by the advantages associated with transradial access, such as reduced recovery time, lower complication rates, and enhanced patient comfort. According to recent data, minimally invasive procedures are projected to grow at a CAGR of approximately 8% over the next five years. As more healthcare facilities adopt these techniques, the transradial access-devices market is likely to expand, reflecting the shift towards less invasive surgical options.

## Future Outlook

The [Transradial Access Devices Market](https://www.marketresearchfuture.com/reports/transradial-access-devices-market-6061) is projected to grow at a 7.46% CAGR from 2025 to 2035, driven by technological advancements and increasing procedural adoption.

**New opportunities:**

- Development of advanced hemostatic devices for improved patient outcomes.
- Expansion into outpatient settings with portable access devices.
- Strategic partnerships with hospitals for integrated access solutions.

By 2035, the market is expected to achieve substantial growth and innovation.

## Segment Insights

### By Product: Catheters (Largest) vs. Guidewires (Fastest-Growing)

In the US transradial access-devices market, catheters hold a significant portion of the market share, making them the largest segment in the product category. Their established use in various medical procedures contributes to their dominance and widespread acceptance among healthcare professionals. This segment benefits from continuous innovation, ensuring that catheters remain a preferred choice in the market.

On the other hand, guidewires are emerging as the fastest-growing segment, reflecting an increasing preference among clinicians for minimally invasive procedures. The growth in this segment is driven by advancements in technology that enhance their performance and reliability. Additionally, the rising demand for less invasive surgical options is propelling the popularity of guidewires, making them a focal point of investment and development in the market.

Catheters (Dominant) vs. Guidewires (Emerging)

Catheters are characterized by their versatility and extensive application in various medical procedures, which contributes to their dominance in the US transradial access-devices market. They are designed for ease of use and compatibility with a range of delivery systems, ensuring effective performance. In contrast, guidewires are emerging with advancements that improve their maneuverability and precision, appealing to surgeons looking for reliable tools for complex procedures. As the healthcare landscape shifts towards minimally invasive interventions, guidewires are seeing increased adoption and development, making them an attractive option for future growth.

### By Application: Drug Administration (Largest) vs. Blood Transfusion (Fastest-Growing)

In the US transradial access-devices market, the Drug Administration segment commands a significant share, establishing itself as the dominant player. This segment benefits from its established role in facilitating efficient drug delivery and has witnessed consistent demand from healthcare providers. In contrast, the Blood Transfusion segment, while currently smaller in market share, is emerging rapidly due to increased awareness and advancements in transfusion techniques, prompting healthcare facilities to adopt transradial access devices more frequently. 

The growth trends within this segment indicate a shift towards minimally invasive procedures, with both Drug Administration and Blood Transfusion benefiting from technological innovations. The increase in chronic disease prevalence and the need for efficient drug administration systems are driving the Drug Administration segment. Additionally, the growing number of surgical and emergency procedures is expanding the role of Blood Transfusion, making it one of the fastest-growing segments in the market.

Drug Administration (Dominant) vs. Blood Transfusion (Emerging)

The Drug Administration segment is characterized by its integral role in healthcare, being the primary method for medication delivery through transradial access devices. This segment enjoys a robust market position due to the continual advancements in drug administration technologies and the increasing volume of outpatient procedures. On the other hand, the Blood Transfusion segment, although still emerging, is recognized for its rapid growth spurred by the rising demand for blood products and advancements in transfusion medicine. As hospitals and medical centers seek to improve patient outcomes, the emphasis on minimizing complications is driving the adoption of innovative and effective devices within this segment. Overall, both segments play essential roles in the evolving landscape of the US transradial access-devices market.

### By Disease Area: Cardiovascular Disease (Largest) vs. Cancer (Fastest-Growing)

The US transradial access-devices market demonstrates a significant focus on various disease areas, with cardiovascular disease representing the largest segment by market share. This segment outpaces others such as cancer and strokes, thanks to the high prevalence and continuing advancements in treatment methodologies. As healthcare systems prioritize effective access methods for cardiovascular interventions, this segment witnesses substantial adoption among practitioners and healthcare institutions.

Conversely, the cancer segment is emerging rapidly, driven by increasing incidences and innovations in treatment technologies, which necessitate enhanced access devices for effective patient management. The demand for advanced transradial access devices in oncology continues to rise, fueled by ongoing research and regulatory support. This dynamic highlights a growing recognition of the necessity and efficacy of these devices in complex cancer treatments.

Cardiovascular Disease: Dominant vs. Cancer: Emerging

Cardiovascular disease remains a dominant force in the US transradial access-devices market, characterized by the widespread prevalence of heart-related conditions and the surgical necessity of minimizing patient recovery times. The segment benefits from established protocols and trusted practices among healthcare professionals, leading to consistent market presence. In contrast, the cancer segment is nascent but promising, representing a growing clinical need as cancer treatments increasingly involve advanced interventional procedures that require specialized access. This shift signifies an evolving landscape where cancer-related procedures are becoming more complex, thereby positioning the transradial approach as a critical component for improving patient outcomes and facilitating safe medical interventions.

### By End User: Hospitals (Largest) vs. Clinics (Fastest-Growing)

In the US transradial access-devices market, hospitals represent the largest share, attributed to their extensive patient base and advanced medical technologies. Clinics are rapidly gaining prominence, accounting for an increasing market share as they offer convenient and cost-effective healthcare solutions. With evolving patient needs, both segments are crucial contributors to the overall growth of this market.

The growth trend in the hospitals segment is primarily driven by the rising number of surgical procedures and the adoption of innovative transradial access devices. Conversely, clinics are emerging as the fastest-growing segment, capitalizing on the shift towards outpatient services and the need for minimally invasive procedures. The convenience offered by clinics is changing patient preferences, making them an attractive option for transradial access.

Hospitals (Dominant) vs. Clinics (Emerging)

Hospitals, as a dominant force in the US transradial access-devices market, possess extensive resources and infrastructure that facilitate the use of advanced access devices. Their ability to integrate cutting-edge technology and maintain a high volume of surgical operations underscores their significance in this sector. In contrast, clinics are becoming an emerging player, characterized by their focus on personalized care and flexibility in service delivery. The growing trend of patients seeking care from clinics stem from factors such as increased accessibility and reduced wait times, positioning them well to capture market share and drive innovation in transradial access solutions.

## Competitive Benchmarking

The transradial access-devices market is characterized by a competitive landscape that is increasingly shaped by innovation and strategic partnerships. Key players such as Boston Scientific Corporation (US), Medtronic plc (IE), and Abbott Laboratories (US) are actively pursuing strategies that emphasize technological advancements and market expansion. Boston Scientific Corporation (US) has focused on enhancing its product portfolio through innovative designs that improve patient outcomes, while Medtronic plc (IE) is leveraging its extensive research capabilities to develop next-generation access devices. Abbott Laboratories (US) appears to be concentrating on strategic collaborations to enhance its market presence, indicating a trend towards cooperative growth among leading firms. Collectively, these strategies contribute to a dynamic competitive environment, where innovation and collaboration are paramount.
In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and improve supply chain efficiency. This approach is particularly relevant in the context of the transradial access-devices market, which is moderately fragmented, with several players vying for market share. The collective influence of key players is significant, as their operational strategies often set benchmarks for industry standards and practices, thereby shaping the overall market structure.
In October 2025, Boston Scientific Corporation (US) announced the launch of a new transradial access device designed to enhance procedural efficiency and patient comfort. This strategic move is likely to reinforce the company's position as a leader in the market, as it addresses the growing demand for minimally invasive procedures. The introduction of this device not only showcases Boston Scientific's commitment to innovation but also reflects a broader trend towards patient-centric solutions in the healthcare sector.
In September 2025, Medtronic plc (IE) entered into a partnership with a leading technology firm to integrate artificial intelligence into its transradial access devices. This collaboration is expected to enhance the precision and safety of procedures, potentially setting a new standard in the industry. By embracing AI, Medtronic is positioning itself at the forefront of technological advancement, which may provide a competitive edge in an increasingly tech-driven market.
In August 2025, Abbott Laboratories (US) expanded its distribution network for transradial access devices across North America, aiming to improve accessibility for healthcare providers. This strategic expansion is indicative of Abbott's focus on enhancing its market reach and ensuring that its innovative products are readily available to a broader audience. Such moves are essential in a market where accessibility can significantly influence competitive positioning.
As of November 2025, the transradial access-devices market is witnessing trends that emphasize digitalization, sustainability, and the integration of advanced technologies. Strategic alliances among key players are shaping the competitive landscape, fostering innovation and enhancing product offerings. Looking ahead, it is anticipated that competitive differentiation will increasingly pivot from price-based strategies to a focus on innovation, technological advancements, and supply chain reliability. This shift underscores the importance of adaptability and forward-thinking in maintaining a competitive edge in the evolving market.

## Recent News & Developments

The US Transradial Access Devices Market has seen significant developments recently, particularly with advancements in technology and product offerings. Companies such as Medtronic and Abbott Laboratories are continually enhancing their transradial access devices with innovations aimed at improving patient outcomes and procedural efficiency. In terms of market growth, the demand for minimally invasive procedures has propelled the valuation of this market segment, with projections indicating a substantial increase in surgical applications. Current affairs also spotlight the collaborative efforts among key players, including Endologix and Terumo, to expand their market reach and product capabilities.

Notably, there have been recent mergers and acquisitions; for instance, in September 2023, Johnson and Johnson announced the acquisition of a digital health platform to enhance its cardiovascular portfolio. Additionally, Boston Scientific has committed to significant investments in Research and Development aimed at new transradial devices. Overall, the focus on safety, efficacy, and patient-centered care continues to drive the trends in the US Transradial Access Devices Market, reflecting the increasing importance of these devices in clinical practice over the past few years.

## Report Scope

| MARKET SIZE 2024 | 362.45(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 389.49(USD Million) |
| MARKET SIZE 2035 | 800.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.46% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Terumo Corporation (JP), Boston Scientific Corporation (US), Medtronic plc (IE), Abbott Laboratories (US), Cardinal Health, Inc. (US), B. Braun Melsungen AG (DE), Johnson & Johnson (US), Cook Medical Incorporated (US) |
| Segments Covered | Product, Application, Disease Area, End User |
| Key Market Opportunities | Advancements in minimally invasive techniques enhance growth potential in the transradial access-devices market. |
| Key Market Dynamics | Technological advancements and regulatory changes drive growth in the transradial access-devices market. |
| Countries Covered | US |

## Frequently Asked Questions

**Q: What is the current market valuation of the US transradial access-devices market?**
A: The market valuation was $362.45 Million in 2024.

**Q: What is the projected market size for the US transradial access-devices market by 2035?**
A: The market is projected to reach $800.0 Million by 2035.

**Q: What is the expected CAGR for the US transradial access-devices market during the forecast period 2025 - 2035?**
A: The expected CAGR is 7.46% during the forecast period 2025 - 2035.

**Q: Which companies are the key players in the US transradial access-devices market?**
A: Key players include Terumo Corporation, Boston Scientific Corporation, Medtronic plc, Abbott Laboratories, Cardinal Health, Inc., B. Braun Melsungen AG, Johnson & Johnson, and Cook Medical Incorporated.

**Q: What are the main product segments in the US transradial access-devices market?**
A: The main product segments are Catheters and Guidewires, with valuations ranging from $200.0 Million to $450.0 Million for Catheters and $162.45 Million to $350.0 Million for Guidewires.

**Q: What applications are driving the US transradial access-devices market?**
A: Key applications include Drug Administration and Blood Transfusion, with valuations between $200.0 Million and $450.0 Million for Drug Administration and $162.45 Million to $350.0 Million for Blood Transfusion.

**Q: Which disease areas are most relevant to the US transradial access-devices market?**
A: Relevant disease areas include Cardiovascular Disease, Cancer, and Strokes, with valuations of $150.0 Million to $350.0 Million for Cardiovascular Disease, $120.0 Million to $250.0 Million for Cancer, and $92.45 Million to $200.0 Million for Strokes.

**Q: Who are the primary end users of transradial access-devices in the US market?**
A: Primary end users are Hospitals and Clinics, with valuations from $250.0 Million to $550.0 Million for Hospitals and $112.45 Million to $250.0 Million for Clinics.

**Q: How does the market for transradial access-devices compare between hospitals and clinics?**
A: The market for Hospitals is larger, with a valuation range of $250.0 Million to $550.0 Million, compared to Clinics, which range from $112.45 Million to $250.0 Million.

**Q: What trends are influencing the growth of the US transradial access-devices market?**
A: Trends include advancements in medical technology and increasing prevalence of cardiovascular diseases, which may drive market growth during the forecast period 2025 - 2035.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-transradial-access-devices-market-56152*